FDA Inspection 1286122 — Biogenex Laboratories, Inc.

Biogenex Laboratories, Inc. — FEI 2936532

The FDA completed an inspection of Biogenex Laboratories, Inc. on Oct 6, 2025 in Fremont, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 6, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Fremont, CA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
2279521 CFR 801.20(a)Label to bear a unique device identifier
73221 CFR 803.50(a)(2)Individual Report of Malfunction

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.